AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects

Summary

This is a phase I, single-blind, randomized, placebo-controlled single and repeated ascending dose study to assess the safety, tolerability and pharmacokinetics with oral doses of AZD1305 extended-release capsules in healthy male Japanese and Caucasian subjects. Three (or four if needed) dose levels will be given to Japanese subjects and one of the doses will also be given to Caucasian subjects.

Timeline

Start

2009-07

Primary completion

2009-11

Completion

2009-11

Drugs

Indications

No indication recorded.